| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.0009 |